Lumexa Imaging surpasses $1B revenue milestone and slashes leverage in 2025
Lumexa Imaging (NASDAQ:LMRI), a premier provider of outpatient diagnostic imaging services, today announced its preliminary, unaudited financial results for the fourth quarter and full year ended December 31, 2025.










